Given the results reported to date, we hypothesized (1) higher sRANKL and lower OPG would be associated with higher risk of breast cancer-associated death among women with ER+ breast cancer; and, (2) a positive association between OPG and risk of breast cancer-associated death among women with ER- disease. Here, TNFRSF11B is linked to breast carcinoma.